Aria Vaishnavi
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Cancer Research and Treatments, Melanoma and MAPK Pathways, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → TRKing Down an Old Oncogene in a New Era of Targeted Therapy(2014)638 cited
- → Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer(2013)602 cited
- → An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101(2015)387 cited
- → RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer(2015)276 cited
- → Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer(2013)135 cited
- → EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases(2017)82 cited
- → BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscape(2024)34 cited
- → Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer(2020)26 cited
- → Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis(2022)24 cited
- → NTRK1 gene fusions as a novel oncogene target in lung cancer.(2013)13 cited